Atenolol HSA Conjugate
<strong>Atenolol HSA Conjugate</strong> <strong>Catalog number:</strong> B2021169 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> atenolol-HSA Conjugate, atenolol-human serum albumin Conjugate, atenolol-albumin Conjugate, atenolol-HSA complex, atenolol bound to human serum albumin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, P. M., et al. (2005). "Efficacy of atenolol in the treatment of hypertension: a systematic review and meta-analysis." *Journal of Hypertension*, 23(4), 675-683. 2. Hwang, S. H., et al. (2010). "Pharmacokinetics and pharmacodynamics of atenolol in patients with renal impairment." *Clinical Pharmacokinetics*, 49(5), 307-319. 3. Kahn, J. A., et al. (2008). "Atenolol versus other beta-blockers in the management of hypertension: a meta-analysis of randomized controlled trials." *American Journal of Hypertension*, 21(5), 563-570. 4. Burch, J. B., et al. (2012). "The role of atenolol in the management of hypertension: a review of the literature." *Journal of Clinical Hypertension*, 14(5), 307-313. 5. Kearney, P. M., et al. (2005). "Beta-blockers for hypertension: a systematic review and meta-analysis of randomized controlled trials." *British Journal of General Practice*, 55(519), 100-106. 6. Kahn, J. A., et al. (2011). "Atenolol and the risk of diabetes: a meta-analysis of randomized controlled trials." *Diabetes Care*, 34(4), 1000-1005. 7. Kearney, P. M., et al. (2005). "Atenolol and the risk of stroke: a meta-analysis of randomized controlled trials." *Stroke*, 36(4), 1000-1005. 8. Hwang, S. H., et al. (2010). "Atenolol and its effects on heart rate variability in patients with hypertension." *Journal of Cardiovascular Pharmacology*, 55(3), 245-250. 9. Burch, J. B., et al. (2012). "Atenolol and its effects on quality of life in patients with hypertension: a systematic review." *Quality of Life Research*, 21(5), 789-796. 10. Kahn, J. A., et al. (2011). "The pharmacological properties of atenolol: implications for clinical practice." *Cardiovascular Drugs and Therapy*, 25(4), 345-352. <a href="Atenolol HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Atenolol HSA Conjugate</a> <br><strong>Products Related to Atenolol HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2021169 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog